Factor V leiden
Clinical trials for Factor V leiden explained in plain language.
Never miss a new study
Get alerted when new Factor V leiden trials appear
Sign up with your email to follow new studies for Factor V leiden, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shot aims to prevent dangerous clots in High-Risk patients
Disease control Recruiting nowThis early-stage study tests a single injection of CITY-FXI, a drug designed to lower clotting risk by targeting a protein called Factor XI. It includes healthy adults and those with Factor V Leiden or prothrombin G20210A mutations, which increase clot risk. The main goal is to c…
Matched conditions: FACTOR V LEIDEN
Phase 1 • Sponsor: City Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New study prepares those with genetic clot risk for future trials
Knowledge-focused Recruiting nowThis study enrolls 100 adults who have or may have Factor V Leiden or Prothrombin G20210A mutations, which increase the risk of blood clots. Participants undergo genetic testing to confirm their status, then attend a site visit for basic health checks like blood pressure, ECG, an…
Matched conditions: FACTOR V LEIDEN
Sponsor: Richmond Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC